Header Leaderboard Ad

Collapse

CDx success insights from Xalkori and Zelboraf

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • CDx success insights from Xalkori and Zelboraf

    4th Molecular Diagnostics for Cancer Drug Development
    Meet the oncology and diagnostics experts you need to deliver better, safer drugs to market quicker
    25 - 28 June 2012, Boston
    www.moleculardiagnostics-cancer.com

    Featuring 31 expert speakers, including:
    • Dr Richard Buller, Vice President, Translational Oncology, Pfizer
    • Dr Miu Chau, Global Head, Companion Diagnostics Operations, Genentech
    • Dr Mitch Raponi, Senior Director, Molecular Diagnostics & Translational Medicine, Clovis Oncology


    This meeting will profile those at the cutting edge of personalized medicine in oncology to give you a thorough review of best practice in end to end drug and diagnostic development from discovery to commercialization.

    For more information please visit the website: www.moleculardiagnostics-cancer.com or get in touch on [email protected].

    Josh Lowth
    Hanson Wade

Latest Articles

Collapse

  • seqadmin
    Improved Targeted Sequencing: A Comprehensive Guide to Amplicon Sequencing
    by seqadmin



    Amplicon sequencing is a targeted approach that allows researchers to investigate specific regions of the genome. This technique is routinely used in applications such as variant identification, clinical research, and infectious disease surveillance. The amplicon sequencing process begins by designing primers that flank the regions of interest. The DNA sequences are then amplified through PCR (typically multiplex PCR) to produce amplicons complementary to the targets. RNA targets...
    03-21-2023, 01:49 PM
  • seqadmin
    Targeted Sequencing: Choosing Between Hybridization Capture and Amplicon Sequencing
    by seqadmin




    Targeted sequencing is an effective way to sequence and analyze specific genomic regions of interest. This method enables researchers to focus their efforts on their desired targets, as opposed to other methods like whole genome sequencing that involve the sequencing of total DNA. Utilizing targeted sequencing is an attractive option for many researchers because it is often faster, more cost-effective, and only generates applicable data. While there are many approaches...
    03-10-2023, 05:31 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 03-24-2023, 02:45 PM
0 responses
11 views
0 likes
Last Post seqadmin  
Started by seqadmin, 03-22-2023, 12:26 PM
0 responses
13 views
0 likes
Last Post seqadmin  
Started by seqadmin, 03-17-2023, 12:32 PM
0 responses
17 views
0 likes
Last Post seqadmin  
Started by seqadmin, 03-15-2023, 12:42 PM
0 responses
22 views
0 likes
Last Post seqadmin  
Working...
X